CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • A bi-faceted role of estrogen receptor   in breast cancer
    E. Leygue and L. C. Murphy
    Endocrine Related Cancer (2013) 20 :R127
  • Triple Immunolabeling in a Single Section of Mammary Gland Using Ki67-MIB1, ER Alpha, and ER Beta Antibodies
    Hermina M. Borgerink and J. Mark Cline
    Journal of Histotechnology (2004) 27 :39
  • Progesterone Receptor Expression in Medroxyprogesterone Acetate-Induced Murine Mammary Carcinomas and Response to Endocrine Treatment
    Luisa A. Helguero, Marcelo Viegas, Aroumougame Asaithamby, Gopalan Shyamala, Claudia Lanari, and Alfredo A. Molinolo
    Breast Cancer Research and Treatment (2003) 79 :379
  • Probing the origin of estrogen receptor alpha inhibition via large-scale QSAR study
    Naravut Suvannang, Likit Preeyanon, Aijaz Ahmad Malik, Nalini Schaduangrat, Watshara Shoombuatong, Apilak Worachartcheewan, Tanawut Tantimongcolwat, and Chanin Nantasenamat
    RSC Advances (2018) 8 :11344
  • Estrogen and progesterone signalling in the normal breast and its implications for cancer development
    Heidi N. Hilton, Christine L. Clarke, and J. Dinny Graham
    Molecular and Cellular Endocrinology (2018) 466 :2
  • The Effects of 17β-estradiol on Mitochondrial Biogenesis and Function in Breast Cancer Cell Lines are Dependent on the ERα/ERβ Ratio
    Jorge Sastre-Serra, Mercedes Nadal-Serrano, Daniel Gabriel Pons, Adamo Valle, Jordi Oliver, and Pilar Roca
    Cellular Physiology and Biochemistry (2012) 29 :261
  • Update on estrogen signaling
    Zhang Weihua, Sandra Andersson, Guojun Cheng, Evan R. Simpson, Margaret Warner, and Jan-Åke Gustafsson
    FEBS Letters (2003) 546 :17
  • Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
    C K Osborne, A Wakeling, and R I Nicholson
    British Journal of Cancer (2004) 90 :S2
  • Clinical significance of estrogen receptor β in breast cancer
    Shigehira Saji, Makiko Hirose, and Masakazu Toi
    Cancer Chemotherapy and Pharmacology (2005) 56 :21
  • Therapeutic targeting in the estrogen receptor hormonal pathway
    Benita S Katzenellenbogen and Jonna Frasor
    Seminars in Oncology (2004) 31 :28
  • Practical Synthesis of FEt-penta-cyclofenil and Its Derivatives for Potential PET Imaging
    Hua Zhu, Liliang Huang, Xiaoping Xu, and Yu-Mei Shen
    Synthetic Communications (2010) 40 :3322
  • Support of a bi-faceted role of estrogen receptor   (ER ) in ER -positive breast cancer cells
    P. Jonsson, A. Katchy, and C. Williams
    Endocrine Related Cancer (2014) 21 :143
  • Effects of triptolide from Tripterygium wilfordii on ERα and p53 expression in two human breast cancer cell lines
    Jing Liu, Zhenzhou Jiang, Jingwei Xiao, Yun Zhang, Sensen Lin, Weigang Duan, Jincheng Yao, Chunhui Liu, Xin Huang, Tao Wang, Zhongliang Liang, Rongrong Wang, Shuang Zhang, and Luyong Zhang
    Phytomedicine (2009) 16 :1006
  • Observations on the presence of E domain variants of estrogen receptor-α in the breast tumors
    Vijay L. Kumar, Suresh Kumar, Anurag Srivastava, and Vijay Kumar
    Journal of Surgical Oncology (2006) 94 :332
  • Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
    Bo Huang, Yoko Omoto, Hirotaka Iwase, Hiroko Yamashita, Tatsuya Toyama, Raoul Charles Coombes, Aleksandra Filipovic, Margaret Warner, and Jan-Åke Gustafsson
    Proceedings of the National Academy of Sciences (2014) 111 :1933
  • Segregated responses of mammary gland development and vaginal opening to prepubertal genistein exposure in Bscl2 −/− female mice with lipodystrophy
    Rong Li, Ahmed E. El Zowalaty, Weiqin Chen, Elizabeth A. Dudley, and Xiaoqin Ye
    Reproductive Toxicology (2015) 54 :76
  • Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12
    Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni, Lorena Landuzzi, Emma Di Carlo, Manuela Iezzi, Cinzia Ricci, Annalisa Astolfi, Stefania Croci, Francesco Marangoni, Piero Musiani, Guido Forni, and Pier-Luigi Lollini
    International Journal of Cancer (2003) 105 :384
  • Expression of Estrogen Receptor Alpha and Beta in Breast Cancers of Pre- and Post-menopausal Women
    Blanca Murillo-Ortiz, Elva Pérez-Luque, J. M. Malacara, Leonel Daza-Benítez, Martha Hernández-González, and Luis Benítez-Bribiesca
    Pathology & Oncology Research (2008) 14 :435
  • Plant foods and oestrogen receptor  - and  -defined breast cancer: observations from the Malmo Diet and Cancer cohort
    E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, G. Landberg, H. Olsson, and E. Wirfalt
    Carcinogenesis (2008) 29 :2203
  • Synthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance target
    Jae Hak Lee, Olaf Peters, Lutz Lehmann, Carmen S. Dence, Terry L. Sharp, Kathryn E. Carlson, Dong Zhou, M. Jeyakumar, Michael J. Welch, and John A. Katzenellenbogen
    Nuclear Medicine and Biology (2012) 39 :1105
  • Estrogen receptors ER  and ER  in proliferation in the rodent mammary gland
    G. Cheng, Z. Weihua, M. Warner, and J.-A. Gustafsson
    Proceedings of the National Academy of Sciences (2004) 101 :3739
  • Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer
    Paula Maguire, Sara Margolin, Johanna Skoglund, Xiao-Feng Sun, Jan-Åke Gustafsson, Anne-Lise Børresen-Dale, and Annika Lindblom
    Breast Cancer Research and Treatment (2005) 94 :145
  • Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state
    Kelly A. Green and Jason S. Carroll
    Nature Reviews Cancer (2007) 7 :713
  • Chaperoning steroid hormone action
    Didier Picard
    Trends in Endocrinology & Metabolism (2006) 17 :229
  • Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer
    C.Kent Osborne and Rachel Schiff
    The Breast (2003) 12 :362
  • Estrogen receptor ?1 and the ?2/?cx isoforms in nonneoplastic endometrium and in endometrioid carcinoma
    D. CHAKRAVARTY, R. SRINIVASAN, S. GHOSH, S. GOPALAN, A. RAJWANSHI, and S. MAJUMDAR
    International Journal of Gynecological Cancer (2007) 17 :905
  • Selective estrogen receptor modulators (SERMS)
    Adolfo Diez-Perez
    Arquivos Brasileiros de Endocrinologia & Metabologia (2006) 50 :720
  • Pathway Analysis Revealed Potential Diverse Health Impacts of Flavonoids that Bind Estrogen Receptors
    Hao Ye, Hui Ng, Sugunadevi Sakkiah, Weigong Ge, Roger Perkins, Weida Tong, and Huixiao Hong
    International Journal of Environmental Research and Public Health (2016) 13 :373
  • The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen
    Eun Ryoung Jang, Soo-Jeong Lim, Eun Sook Lee, Gajin Jeong, Tae-You Kim, Yung-Jue Bang, and Jong-Soo Lee
    Oncogene (2004) 23 :1724
  • Histone deacetylase inhibition and estrogen signalling in human breast cancer cells
    Raphaël Margueron, Vanessa Duong, Audrey Castet, and Vincent Cavaillès
    Biochemical Pharmacology (2004) 68 :1239
  • Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells
    D. Behrens, J.H. Gill, and I. Fichtner
    Molecular and Cellular Endocrinology (2007) 274 :19
  • Multifunctional molecular imaging probes for estrogen receptors: 99mTc labeled diethylstilbestrol (DES) conjugated, cuinp quantum dot nanoparticles (DESCIP)
    Payam Moharrami, Perihan Unak, Ozge Kozguş Guldu, E. İ. Medine, Gul Gumuser, Elvan Sayıt Bilgin, and Omer Aras
    Journal of Radioanalytical and Nuclear Chemistry (2017) 314 :2609
  • Cancérogenèse hormonale chez la femme : des mécanismes à la prévention
    Henri Rochefort
    Comptes Rendus Biologies (2008) 331 :104
  • Estrogen Carcinogenesis in Breast Cancer
    Doris Germain
    Endocrinology and Metabolism Clinics of North America (2011) 40 :473
  • Targeting the genotoxic effects of estrogens
    Monica M. Montano, Nirmala Krishnamurthy, and Smitha Sripathy
    Drug Discovery Today: Disease Mechanisms (2012) 9 :e29
  • Characterization of the ER -/-mouse heart
    C. Forster, S. Kietz, K. Hultenby, M. Warner, and J.-A. Gustafsson
    Proceedings of the National Academy of Sciences (2004) 101 :14234
  • Differential Expression of Hormonal and Growth Factor Receptors in Salivary Duct Carcinomas
    Michelle D. Williams, Dianna Roberts, George R. Blumenschein, Stephane Temam, Merrill S. Kies, David I. Rosenthal, Randal S. Weber, and Adel K. El-Naggar
    The American Journal of Surgical Pathology (2007) 31 :1645
  • Estrogen and progesterone receptors in esophageal carcinoma
    R. Kalayarasan, N. Ananthakrishnan, V. Kate, and D. Basu
    Diseases of the Esophagus (2008) 21 :298
  • Computational Polypharmacology Analysis of the Heat Shock Protein 90 Interactome
    Andrew Anighoro, Dagmar Stumpfe, Kathrin Heikamp, Kristin Beebe, Leonard M. Neckers, Jürgen Bajorath, and Giulio Rastelli
    Journal of Chemical Information and Modeling (2015) 55 :676
  • Differential expression and comparative subcellular localization of estrogen receptor beta isoforms in virally transformed and normal cultured human lens epithelial cells
    Patrick R. Cammarata, James Flynn, Srinivas Gottipati, Shaoyou Chu, Slobadan Dimitrijevich, Mamoun Younes, George Skliris, and Leigh C. Murphy
    Experimental Eye Research (2005) 81 :165
  • The expression of ERα, ERβ and PR in lobular carcinomain situof the breast determined using laser microdissection and real-time PCR
    Andrew R Green, Peter Young, Sophie Krivinskas, Emad A Rakha, E Claire Paish, Desmond G Powe, and Ian O Ellis
    Histopathology (2009) 54 :419
  • Estrogen Receptor β of Host Promotes the Progression of Lung Cancer Brain Metastasis of an Orthotopic Mouse Model
    Lei Xu, Guang Gao, Jiangong Ren, Fei Su, and Zhang Weihua
    Journal of Cancer Therapy (2012) 03 :352
  • Cyclopia Extracts Act as ERα Antagonists and ERβ Agonists, In Vitro and In Vivo
    Koch Visser, Morné Mortimer, Ann Louw, and Wei Xu
    PLoS ONE (2013) 8 :e79223
  • Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells
    Giovanni Nassa, Roberta Tarallo, Pietro H. Guzzi, Lorenzo Ferraro, Francesca Cirillo, Maria Ravo, Ernesto Nola, Marc Baumann, Tuula A. Nyman, Mario Cannataro, Concetta Ambrosino, and Alessandro Weisz
    Mol. BioSyst. (2011) 7 :667
  • Cancer therapy using natural ligands that target estrogen receptor beta
    Gangadhara R Sareddy and Ratna K. Vadlamudi
    Chinese Journal of Natural Medicines (2015) 13 :801
  • Open Sandwich FRET Immunoassay of Estrogen Receptor β in a PDMS Microfluidic Channel
    Bulletin of the Korean Chemical Society (2008) 29 :1297
  • Synthesis and evaluation of fluoroethyl cyclofenil analogs: Models for potential estrogen receptor imaging agent
    Hua Zhu, Zhi Yang, Jian-Guo Lin, Shi-Neng Luo, and Yu-Mei Shen
    Journal of Fluorine Chemistry (2012) 139 :46
  • Sex Hormone Receptor Repertoire in Breast Cancer
    Gerald M. Higa and Ryan G. Fell
    International Journal of Breast Cancer (2013) 2013 :1
  • Estrogen rapid action via protein complex formation involving ERα and Src
    Robert X-D. Song, Zhenguo Zhang, and Richard J. Santen
    Trends in Endocrinology & Metabolism (2005) 16 :347
  • Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
    Hiroko Yamashita, Mariko Nishio, Shunzo Kobayashi, Yoshiaki Ando, Hiroshi Sugiura, Zhenhuan Zhang, Maho Hamaguchi, Keiko Mita, Yoshitaka Fujii, and Hirotaka Iwase
    Breast Cancer Research (2005) 7 :
  • Novel estrogen receptor coactivator PELP1/MNAR gene and ERβ expression in salivary duct adenocarcinoma: potential therapeutic targets
    Ratna K. Vadlamudi, Seetharaman Balasenthil, Aysegul A. Sahin, Merrill Kies, Randal S. Weber, Rakesh Kumar, and Adel K. El-Naggar
    Human Pathology (2005) 36 :670
  • ERβ shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins
    Jin-Qiang Chen, Patricia A. Russo, Carol Cooke, Irma H. Russo, and Jose Russo
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2007) 1773 :1732
  • Estrogen receptor status of breast stromal cells
    Kevin C. Knower, Ashwini L. Chand, and Colin D. Clyne
    Breast Cancer Research and Treatment (2014) 143 :609
  • Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog
    Amruta Ronghe, Anwesha Chatterjee, Bhupendra Singh, Prasad Dandawate, Leigh Murphy, Nimee K. Bhat, Subhash Padhye, and Hari K. Bhat
    The Journal of Steroid Biochemistry and Molecular Biology (2014) 144 :500
  • Insufficient antibody validation challenges oestrogen receptor beta research
    Sandra Andersson, Mårten Sundberg, Nusa Pristovsek, Ahmed Ibrahim, Philip Jonsson, Borbala Katona, Carl-Magnus Clausson, Agata Zieba, Margareta Ramström, Ola Söderberg, Cecilia Williams, and Anna Asplund
    Nature Communications (2017) 8 :15840
  • Effects of raloxifene on the mammary epithelium of female rats in persistent estrus
    Ludmila T. Nogueira and Benedito B. da Silva
    Gynecological Endocrinology (2009) 25 :357
  • Reporter gene assay demonstrates functional differences in estrogen receptor activity in purified breast cancer cells: A pilot study
    Anjana Singh, Simak Ali, Manish S. Kothari, Manuela Tamburo De Bella, Clive Smith, Emma Timms, Martin J. Slade, Brian M. Foxwell, and R. Charles Coombes
    International Journal of Cancer (2003) 107 :700
  • Effect of pregnancy and feeding level on cell turnover and expression of related genes in the mammary tissue of lactating dairy cows
    J. V. Nørgaard, M. T. Sørensen, P. K. Theil, J. Sehested, and K. Sejrsen
    animal (2008) 2 :
  • A Multi-Centre Investigation Towards Reaching a Consensus on the Immunohistochemical Detection of ERβ in Archival Formalin-fixed Paraffin Embedded Human Breast Tissue
    Pauline J. Carder, Claire E. Murphy, Peter Dervan, Maria Kennedy, Amanda McCann, Philippa T. K. Saunders, Abeer M. Shaaban, Christopher S. Foster, Caroline J. Witton, John M. S. Bartlett, Rosemary A. Walker, and Valerie Speirs
    Breast Cancer Research and Treatment (2005) 92 :287
  • Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway
    Véronique St-Laurent, Mélanie Sanchez, Catherine Charbonneau, and André Tremblay
    The Journal of Steroid Biochemistry and Molecular Biology (2005) 94 :23
  • Antiestrogenic Activity of Triptolide in Human Breast Cancer Cells MCF-7 and Immature Female Mouse
    Yi Tang, Jun Wang, Jinghua Cheng, and Lijun Wang
    Drug Development Research (2017) 78 :164
  • Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications
    Jin-Qiang Chen, James D. Yager, and Jose Russo
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2005) 1746 :1
  • Estrogen Receptor ?? in Breast Cancer: Associations Between ER??, Hormonal Receptors, and Other Prognostic Biomarkers
    Young Choi and Marguerite Pinto
    Applied Immunohistochemistry & Molecular Morphology (2005) 13 :19
  • Expression of estrogen receptor β isoforms in normal breast epithelial cells and breast cancer: regulation by methylation
    Chunyan Zhao, Eric W-F Lam, Andrew Sunters, Eva Enmark, Manuela Tamburo De Bella, R Charles Coombes, Jan-Åke Gustafsson, and Karin Dahlman-Wright
    Oncogene (2003) 22 :7600
  • Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
    Stina Garvin, Karin Öllinger, and Charlotta Dabrosin
    Cancer Letters (2006) 231 :113
  • A 2009 Update on the Treatment of Patients with Hormone Receptor—Positive Breast Cancer
    Susan J. Cleator, Eliyaz Ahamed, R. Charles Coombes, and Carlo Palmieri
    Clinical Breast Cancer (2009) 9 :S6
  • Molecular action of the estrogen receptor and hormone dependency in breast cancer
    Hirotaka Iwase
    Breast Cancer (2003) 10 :89
  • Effect of in vitro estrogenic pesticides on human oestrogen receptor α and β mRNA levels
    H.T Grünfeld and E.C Bonefeld-Jorgensen
    Toxicology Letters (2004) 151 :467
  • Deconstructing estradiol: Removal of B-ring generates compounds which are potent and subtype-selective estrogen receptor agonists
    Mohammud Asim, Mohamed El-Salfiti, Yiming Qian, Christine Choueiri, Samira Salari, James Cheng, Hooman Shadnia, Manpartap Bal, M.A. Christine Pratt, Kathryn E. Carlson, John A. Katzenellenbogen, James S. Wright, and Tony Durst
    Bioorganic & Medicinal Chemistry Letters (2009) 19 :1250
  • Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression
    Cecilia Williams, Luisa Helguero, Karin Edvardsson, Lars-Arne Haldosén, and Jan-Åke Gustafsson
    Breast Cancer Research (2009) 11 :
  • Effects of lifelong exercise training on mammary tumorigenesis induced by MNU in female Sprague–Dawley rats
    Ana I. Faustino-Rocha, Adelina Gama, Paula A. Oliveira, Antonieta Alvarado, Maria J. Neuparth, Rita Ferreira, and Mário Ginja
    Clinical and Experimental Medicine (2017) 17 :151
  • Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-β connection
    Wen G. Jiang, Gaynor Davies, and Oystein Fodstad
    Biochemical and Biophysical Research Communications (2005) 330 :253
  • Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met
    M. Mortimer, K. Visser, D. de Beer, E. Joubert, A. Louw, and Arun Rishi
    PLOS ONE (2015) 10 :e0132950
  • Nonlinear partial differential equations and applications: Involvement of estrogen receptor   in terminal differentiation of mammary gland epithelium
    C. Forster, S. Makela, A. Warri, S. Kietz, D. Becker, K. Hultenby, M. Warner, and J.-A. Gustafsson
    Proceedings of the National Academy of Sciences (2002) 99 :15578
  • Expression of Estrogen Receptor-β in Normal Mammary and Tumor Tissues: is it Protective in Breast Carcinogenesis?
    Byeong-Woo Park, Ki-Suk Kim, Min-Kyu Heo, Seung-Sang Ko, Kyong Sik Lee, Soon Won Hong, Woo-Ick Yang, Joo-Hang Kim, and Gwi Eon Kim
    Breast Cancer Research and Treatment (2003) 80 :79
  • Sterility and absence of histopathological defects in nonreproductive organs of a mouse ER -null mutant
    M. C. Antal, A. Krust, P. Chambon, and M. Mark
    Proceedings of the National Academy of Sciences (2008) 105 :2433
  • Aromatase inhibitors and other novel agents in breast cancer treatment
    Shigehira Saji and Masakazu Toi
    Expert Opinion on Emerging Drugs (2002) 7 :303
  • 2,5-Diphenylfuran-based pure antiestrogens with selectivity for the estrogen receptor α
    Jochen Zimmermann, Renate Liebl, and Erwin von Angerer
    The Journal of Steroid Biochemistry and Molecular Biology (2005) 94 :57
  • A critical view of the effects of phytoestrogens on hot flashes and breast cancer risk
    Pascale This, Patricia de Cremoux, Guy Leclercq, and Yves Jacquot
    Maturitas (2011) 70 :222
  • Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
    Marc Lacroix and Guy Leclercq
    Breast Cancer Research and Treatment (2004) 83 :249
  • Both N- and C-terminal transactivation functions of DNA-bound ERα are blocked by a novel synthetic estrogen ligand
    Yasuji Yamamoto, Osamu Wada, Ichiro Takada, Yoshiko Yogiashi, Jiro Shibata, Junn Yanagisawa, Kenji Kitazato, and Shigeaki Kato
    Biochemical and Biophysical Research Communications (2003) 312 :656
  • Steroid-Functionalized Titanocenes: Docking Studies with Estrogen Receptor Alpha
    Li Gao, Wilson Maldonado, Xiomara Narváez-Pita, José Carmona-Negrón, Jesus Olivero-Verbel, and Enrique Meléndez
    Inorganics (2016) 4 :38
  • Estrogen receptor β ligands: Recent advances and biomedical applications
    Filippo Minutolo, Marco Macchia, Benita S. Katzenellenbogen, and John A. Katzenellenbogen
    Medicinal Research Reviews (2011) 31 :364
  • Impact of hypoxia inducible factors on estrogen receptor expression in breast cancer cells
    Matthias Wolff, Friederike Katharina Kosyna, Jürgen Dunst, Wolfgang Jelkmann, and Reinhard Depping
    Archives of Biochemistry and Biophysics (2017) 613 :23
  • Immunolocalization of estrogen and progesterone receptors in ewe mammary glands
    M. Colitti and F. Parillo
    Microscopy Research and Technique (2013) 76 :955
  • Effects of the pesticides prochloraz and methiocarb on human estrogen receptor α and β mRNA levels analyzed by on-line RT-PCR
    M.V. Hofmeister and E.C. Bonefeld-Jørgensen
    Toxicology in Vitro (2004) 18 :427
  • Design, synthesis, and evaluation of cyclofenil derivatives for potential SPECT imaging agents
    Hua Zhu, Liliang Huang, Yuanqing Zhang, Xiaoping Xu, Yanhong Sun, and Yu-Mei Shen
    JBIC Journal of Biological Inorganic Chemistry (2010) 15 :591
  • Expression of estrogen receptors-α and -β in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy
    L. M. Bershtein, T. E. Poroshina, T. S. Zimarina, E. V. Tsyrlina, E. K. Zhil’tsova, A. Yu. Kovalevskii, and V. F. Semiglazov
    Bulletin of Experimental Biology and Medicine (2004) 138 :494
  • Targeted functional imaging in breast cancer
    Rakesh Kumar
    European Journal of Nuclear Medicine and Molecular Imaging (2007) 34 :346
  • Hormonal Resistance in Breast Cancer: Evolving Treatment Strategies
    Mustafa Khasraw, Sandra L. Harvey, and Richard Bell
    Current Breast Cancer Reports (2012) 4 :66
  • Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion
    Nadine Platet, Anne Marie Cathiard, Michel Gleizes, and Marcel Garcia
    Critical Reviews in Oncology/Hematology (2004) 51 :55
  • Equol, a natural estrogenic metabolite from soy isoflavones
    Rajeev S Muthyala, Young H Ju, Shubin Sheng, Lee D Williams, Daniel R Doerge, Benita S Katzenellenbogen, William G Helferich, and John A Katzenellenbogen
    Bioorganic & Medicinal Chemistry (2004) 12 :1559
  • Estrogen Receptor α and Progesterone Receptor Expression in Ovarian Adult Granulosa Cell Tumors and Sertoli-Leydig Cell Tumors
    Maryam A. Farinola, Allen M. Gown, Kara Judson, Brigitte M. Ronnett, Todd S. Barry, Saeid Movahedi-Lankarani, and Russell Vang
    International Journal of Gynecological Pathology (2007) 26 :375
  • Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
    Pankaj Taneja, Dejan Maglic, Fumitake Kai, Sinan Zhu, Robert D. Kendig, A. Fry Elizabeth, and Kazushi Inoue
    Clinical Medicine Insights: Oncology (2010) 4 :CMO.S4773
  • Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions
    Giovanni P Burrai, Sulma I Mohammed, Margaret A Miller, Vincenzo Marras, Salvatore Pirino, Maria F Addis, Sergio Uzzau, and Elisabetta Antuofermo
    BMC Cancer (2010) 10 :
  • DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status
    Isabel Conde, Juan M Alfaro, Benito Fraile, Antonio Ruíz, Ricardo Paniagua, and Maria I Arenas
    Breast Cancer Research (2004) 6 :
  • ERβ in breast cancer—Onlooker, passive player, or active protector?
    Emily M. Fox, Rebecca J. Davis, and Margaret A. Shupnik
    Steroids (2008) 73 :1039
  • Estrogen receptor β- an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?
    BJØRN O. MAEHLE, KARIN COLLETT, STEINAR TRETLI, LARS A. AKSLEN, and TOM GROTMOL
    APMIS (2009) 117 :644
  • Estrogen receptor beta in breast cancer
    Lars-Arne Haldosén, Chunyan Zhao, and Karin Dahlman-Wright
    Molecular and Cellular Endocrinology (2014) 382 :665
  • Ligand-Induced Regulation of ERα and ERβ is Indicative of Human Breast Cancer Cell Proliferation
    Krista A. Power and Lilian U. Thompson
    Breast Cancer Research and Treatment (2003) 81 :209
  • New computational strategy to analyze the interactions of ERα and ERβ with different ERE sequences
    Anna Marabotti, Giovanni Colonna, and Angelo Facchiano
    Journal of Computational Chemistry (2007) 28 :1031
  • Estradiol-estrogen receptor: A key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells
    Olga Ch. Kousidou, Aikaterini Berdiaki, Dimitris Kletsas, Alexandros Zafiropoulos, Achilleas D. Theocharis, George N. Tzanakakis, and Nikos K. Karamanos
    Molecular Oncology (2008) 2 :223
  • Clinical impact of assay of estrogen receptor βcx in breast cancer
    Shigehira Saji, Yoko Omoto, Chikako Shinizu, Shin-ichiro Horiguchi, Toru Watanabe, Nobuaki Funata, Shin-ichi Hayashi, Jan-Åke Gustafsson, and Masakazu Toi
    Breast Cancer (2002) 9 :303
  • Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues
    Kemal Kürşat Bozkurt and Nilgün Kapucuoğlu
    Pathology - Research and Practice (2012) 208 :133
  • Opposing Action of Estrogen Receptors α and β on Tumor Necrosis Factor-α Gene Expression and Caspase-8-mediated Apoptotic Effects in HA22T Cells
    Erh-Jung Huang, Cheng-Chung Wu, Shin-Da Lee, Juen-Hau Chen, Jer-Yuh Liu, Jiunn-Liang Ko, James A. Lin, Min-Chi Lu, Li-Mien Chen, Chih-Yang Huang, and Wei-Wen Kuo
    Molecular and Cellular Biochemistry (2006) 287 :137
  • What pharmacologists can learn from recent advances in estrogen signalling
    Jan-Åke Gustafsson
    Trends in Pharmacological Sciences (2003) 24 :479
  • Estrogen receptor α/β isoforms, but not βcx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells
    Frank J. Secreto, David G. Monroe, Shamit Dutta, James N. Ingle, and Thomas C. Spelsberg
    Journal of Cellular Biochemistry (2007) 101 :1125
  • Estrogen receptor   inhibits 17 -estradiol-stimulated proliferation of the breast cancer cell line T47D
    A. Strom, J. Hartman, J. S. Foster, S. Kietz, J. Wimalasena, and J.-A. Gustafsson
    Proceedings of the National Academy of Sciences (2004) 101 :1566
  • MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer
    Neha Nagpal, Hafiz M. Ahmad, Bhuvan Molparia, and Ritu Kulshreshtha
    Carcinogenesis (2013) 34 :1889
  • Fulvestrant, a selective estrogen receptor down-regulator, sensitizes estrogen receptor negative breast tumors to chemotherapy
    Donghai Jiang, Yuan Huang, Ning Han, Mingjie Xu, Liang Xu, Lin Zhou, Shu Wang, and Weimin Fan
    Cancer Letters (2014) 346 :292
  • Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology
    Hope Burks, Nicholas Pashos, Elizabeth Martin, John Mclachlan, Bruce Bunnell, and Matthew Burow
    Molecular and Cellular Endocrinology (2017) 457 :13
  • Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5- b ]pyridine
    Cunping Qiu, Liang Shan, Minshu Yu, and Elizabeth G. Snyderwine
    Carcinogenesis (2005) 26 :763
  • A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells
    C Williams, K Edvardsson, S A Lewandowski, A Ström, and J-Å Gustafsson
    Oncogene (2008) 27 :1019
  • Development and validation of fluorescent receptor assays based on the human recombinant estrogen receptor subtypes alpha and beta
    Theo de Boer, Debby Otjens, Alex Muntendam, Eric Meulman, Martine van Oostijen, and Kees Ensing
    Journal of Pharmaceutical and Biomedical Analysis (2004) 34 :671
  • Oestrogen receptor β: what it means for patients with breast cancer
    Valerie Speirs, Pauline J Carder, Sally Lane, David Dodwell, Mark RJ Lansdown, and Andrew M Hanby
    The Lancet Oncology (2004) 5 :174
  • The biological role of estrogen receptors α and β in cancer
    Sandra Timm Pearce and V.Craig Jordan
    Critical Reviews in Oncology/Hematology (2004) 50 :3
  • The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17Beta-estradiol
    Mercedes Nadal-Serrano, Jorge Sastre-Serra, Daniel Gabriel Pons, Antonia María Miró, Jordi Oliver, and Pilar Roca
    Journal of Cellular Biochemistry (2012) 113 :3178
  • Induction of quinone reductase by tamoxifen or DPN protects against mammary tumorigenesis
    Nirmala Krishnamurthy, Yanduan Hu, Sandra Siedlak, Yong Qiu Doughman, Michiko Watanabe, and Monica M. Montano
    The FASEB Journal (2012) 26 :3993
  • Belamcanda chinensis and the thereof purified tectorigenin have selective estrogen receptor modulator activities
    D Seidlová-Wuttke, O Hesse, H Jarry, G Rimoldi, P Thelen, V Christoffel, and W Wuttke
    Phytomedicine (2004) 11 :392
  • Progesterone receptors A and B and estrogen receptor alpha expression in normal breast tissue and fibroadenomas
    Gisele Branchini, Lolita Schneider, Rodrigo Cericatto, Edison Capp, and Ilma Simoni Brum
    Endocrine (2009) 35 :459
  • The role of IL17B-IL17RB signaling pathway in breast cancer
    Vahideh Alinejad, Sanam Dolati, Morteza Motallebnezhad, and Mehdi Yousefi
    Biomedicine & Pharmacotherapy (2017) 88 :795